Related Experiment Video

Updated: May 27, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Survival after immunosuppressive therapy in children with aplastic anemia

Velu Nair1, Vishal Sondhi, Ajay Sharma

  • 1Department of Medicine, Armed Forces Medical College, Pune, Maharashtra, India. profvelunair@gmail.com

Indian Pediatrics
|November 15, 2011
PubMed

Insights

Children with acquired aplastic anemia treated with immunosuppressive therapy (IST) including equine antithymocyte globulin and cyclosporine show excellent survival rates. Granulocyte-colony stimulating factor (G-CSF) reduced infections but did not impact survival.

Area of Science:

  • Pediatric Hematology
  • Immunosuppressive Therapy
  • Aplastic Anemia Research

Background:

  • Acquired aplastic anemia (AAA) is a rare but serious condition.
  • Immunosuppressive therapy (IST) is a standard treatment for AAA.
  • Equine antithymocyte globulin (e-ATG) and cyclosporine (CsA) are commonly used in IST regimens.

Purpose of the Study:

  • To evaluate the survival outcomes of pediatric patients with AAA treated with e-ATG and CsA.
  • To assess the efficacy of IST in achieving treatment response.
  • To determine the impact of G-CSF on complications and survival.

Main Methods:

  • Prospective data collection from 40 children diagnosed with AAA between 1998 and 2009.
  • Analysis of 33 patients who received IST (e-ATG and CsA).
  • Evaluation of overall response and overall survival as primary outcome measures.

Main Results:

  • An overall response rate of 87.9% was observed at 6 months post-IST.
  • Overall survival was 90% at 24 months and 85.4% at 5 years.
  • G-CSF administration was associated with fewer infectious complications (P=0.002) but did not affect survival.

Conclusions:

  • Pediatric patients responding to IST for AAA demonstrate excellent long-term survival.
  • G-CSF can be beneficial in reducing infectious complications in these patients.
  • IST remains a highly effective treatment strategy for acquired aplastic anemia in children.
Abstract

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...